Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...
Some developers and public beta testers can now share lost AirTags and other device information with others to find the item.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback